Indoco Remedies shares rise 7% on USFDA approval for Brivaracetam oral solution
approval-for-rivaracetam-oral-solution'>Indoco Remedies shares rise 7% on USFDA approval for Brivaracetam oral solution is drawing significant interest across the industry.
The approval allows Indoco to market a generic equivalent of Briviact 10 mg/mL, the reference listed drug of UCB, Inc., in the United States.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Cost of home heating oil in NI fluctuates ahead of cold snap
- Experts say getting at least 7 hours sleep a night can help you live longer - these gadgets, from $16 can help you hit that goal
- Haryana Plans ‘CM Shri Schools’ on PM SHRI Lines; RTE Quota Reinforced
- Netflix New Releases: March 2026
Source: Original →